Is AMGN or GILD cheaper?

On trailing earnings, GILD is cheaper: AMGN trades at a 24.72 P/E and GILD at 17.11.

Which has grown faster, AMGN or GILD?

Over the past five years, AMGN grew revenue faster — AMGN at a 8.15% CAGR versus GILD at 3.07%.

Does AMGN or GILD pay a bigger dividend?

AMGN yields 2.76% and GILD yields 1.91% based on trailing dividends and the latest price.

Is AMGN or GILD more profitable?

GILD runs the higher net margin — AMGN at 20.95% versus GILD at 30.99%.

Which has been the better investment, AMGN or GILD?

Over the past 10-year, AMGN delivered the higher annualized total return — AMGN at 11.94% versus GILD at 7.79%. Past performance doesn't predict future results.

Amgen Inc. (AMGN) vs Gilead Sciences, Inc. (GILD)

GILD leads on 13 of 17 compared metrics.

A side-by-side comparison of Amgen Inc. and Gilead Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Gilead Sciences, Inc.

$155.93B

$125.59Healthcare

Total return — AMGN vs GILD

growth of $100 · last 30y

AMGN +2282.3%GILD +13408.8%GILD compounded faster

Log scale — wide-divergence pair

AMGN GILD

AMGN vs GILD: by the numbers

•AMGN is the larger company ($191.70B vs $155.93B market cap).
•GILD trades at the lower earnings multiple (17.11 vs 24.72 P/E).
•GILD converts more revenue to profit (30.99% vs 20.95% net margin).
•AMGN grew revenue faster over the past five years (8.15% vs 3.07% CAGR).
•AMGN pays the higher dividend yield (2.76% vs 1.91%).

Which is better, AMGN or GILD?

Metric tally: AMGN 4 · GILD 13

It depends on what you're optimizing for:

ValueGILD(lower P/E)

GrowthAMGN(faster 5Y revenue CAGR)

IncomeAMGN(higher dividend yield)

QualityGILD(higher ROIC)

Valuation

Metric	AMGN	GILD
P/E ratio	24.72	17.11●
Forward P/E	15.15	13.00●
P/S ratio	5.19●	5.30
P/B ratio	21.03	6.70●
PEG ratio	0.26	0.01●
EV / EBITDA	15.32	12.91●
FCF yield	4.45%	6.49%●

Profitability

Metric	AMGN	GILD
Gross margin	71.46%	79.35%●
Operating margin	31.63%	38.26%●
Net margin	20.95%	30.99%●
ROE	84.87%●	39.19%
ROIC	13.16%	21.53%●

Dividends

Metric	AMGN	GILD
Dividend yield	2.76%●	1.91%
Payout ratio	68.39%	35.09%

Growth (annualized)

Metric	AMGN	GILD
Revenue CAGR (5Y)	8.15%●	3.07%
EPS CAGR (5Y)	2.94%	133.83%●
FCF CAGR (5Y)	-2.66%	3.30%●
Total return CAGR (5Y)	11.36%	17.06%●

Frequently asked

Which is better, AMGN or GILD?: It depends on your goal. value: GILD (lower P/E); growth: AMGN (faster 5Y revenue CAGR); income: AMGN (higher dividend yield); quality: GILD (higher ROIC). Across all compared metrics, GILD leads 13 to 4.
Is AMGN or GILD cheaper?: On trailing earnings, GILD is cheaper: AMGN trades at a 24.72 P/E and GILD at 17.11.
Which has grown faster, AMGN or GILD?: Over the past five years, AMGN grew revenue faster — AMGN at a 8.15% CAGR versus GILD at 3.07%.
Does AMGN or GILD pay a bigger dividend?: AMGN yields 2.76% and GILD yields 1.91% based on trailing dividends and the latest price.
Is AMGN or GILD more profitable?: GILD runs the higher net margin — AMGN at 20.95% versus GILD at 30.99%.
Which has been the better investment, AMGN or GILD?: Over the past 10-year, AMGN delivered the higher annualized total return — AMGN at 11.94% versus GILD at 7.79%. Past performance doesn't predict future results.

Go deeper

Full AMGN analysis Full GILD analysis Interactive comparison tool

Dig into the metrics

Amgen P/E ratio Gilead Sciences P/E ratio Amgen dividend yield Gilead Sciences dividend yield Amgen ROE Gilead Sciences ROE Amgen operating margin Gilead Sciences operating margin Amgen revenue growth Gilead Sciences revenue growth Amgen free cash flow Gilead Sciences free cash flow

Amgen & Gilead Sciences appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.